SuperworthFortress Biotech shares outstanding FBIO
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 31.8M
- On a year earlier
- +6.6%
- more shares
Fortress Biotech had 31.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 6.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 30.4M | +17% |
| FY2024 | 26M | +142% |
| FY2023 | 10.7M | +78% |
| FY2022 | 6M | +8% |
| FY2021 | 5.6M | +5% |
| FY2020 | 5.3M | +34% |
| FY2019 | 4M | +38% |
| FY2018 | 2.9M | −4% |
| FY2017 | 3M | +12% |
| FY2016 | 2.7M | +2% |
| FY2015 | 2.6M | +6% |
| FY2014 | 2.5M | +5% |
| FY2013 | 2.4M | +46% |
| FY2012 | 1.6M | +89% |
| FY2011 | 860.1K | +171% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 31.8M | +7% | |
| Q1 FY26 | 38.4M | +45% | |
| Q4 FY25 | 30.4M | +17% | |
| Q3 FY25 | 33.1M | +68% | |
| Q2 FY25 | 29.8M | +63% | |
| Q1 FY25 | 26.5M | +54% | |
| Q4 FY24 | 26M | +142% | |
| Q3 FY24 | 19.7M | +163% | |
| Q2 FY24 | 18.3M | +148% | |
| Q1 FY24 | 17.2M | +153% | |
| Q4 FY23 | 10.7M | +78% | |
| Q3 FY23 | 7.5M | +26% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Fortress Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.